| 注册
首页|期刊导航|中国医学创新|颜氏益心方干预代谢综合征及对脂肪细胞因子影响的临床研究

颜氏益心方干预代谢综合征及对脂肪细胞因子影响的临床研究

庞宁 陈惠娟

中国医学创新2016,Vol.13Issue(32):67-69,70,4.
中国医学创新2016,Vol.13Issue(32):67-69,70,4.DOI:10.3969/j.issn.1674-4985.2016.32.019

颜氏益心方干预代谢综合征及对脂肪细胞因子影响的临床研究

Effect of Yanshi Yixin Fang on Metabolic Syndrome and Adipocyte Factor

庞宁 1陈惠娟1

作者信息

  • 1. 广州市东升医院 广东 广州 510000
  • 折叠

摘要

Abstract

Objective:To observe the effect of Yanshi Yixin Fang on metabolic syndrome and adipocyte factors. Method:This study was performed from Feb 2015 to Feb 2016,a total of 100 patients with metabolic syndrome were admitted to Guangzhou Dongsheng Hospital,and then were randomly divided into the treatment group (n=50) and the control group (n=50).The control group was treated with oral Captopril,Simvastatin as well as Metformin,and the treatment group received oral Captopril, Simvastatin, Metformin together with Yan Shi Yixin Fang treatment.Differences of biochemical indexes and fat cells factor of two groups before and after treatment were performed.Result:The biochemical indexes and fat cells factor were improved both in control group and treatment group after treatment, including fasting plasma glucose (FPG), insulin resistance index (IR) and blood pressure.Furthermore,cholesterol and low density lipoprotein cholesterol were significantly decreased in control group and treatment group (P>0.05), in contrast, high density lipoprotein cholesterol was notably increased of two groups (P<0.05).In addition,resistin, adiponectin, plasminogen activator inhibitor content were markedly improved (P<0.05).Conclusion:Yan shi Yixin Fang has the efficacy of interventions on metabolic syndrome as well as regulations adipokines.

关键词

颜氏益心方/代谢综合征/脂肪细胞因子

Key words

Yanshi Yixin Fang/Metabolic syndrome/Adipocyte factor

引用本文复制引用

庞宁,陈惠娟..颜氏益心方干预代谢综合征及对脂肪细胞因子影响的临床研究[J].中国医学创新,2016,13(32):67-69,70,4.

基金项目

广东省中医药管理局科研基金项目 ()

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文